Loading clinical trials...
Loading clinical trials...
Enteric Coated Mycophenolic Acid (Myfortic) in Liver Transplant Recipients- Effect on Compliance and Calcineurin Inhibitor and Corticosteroid Sparing
Conditions
Interventions
Myfortic
Locations
1
United States
Memorial Hermann Hospital
Houston, Texas, United States
Start Date
September 1, 2005
Primary Completion Date
February 1, 2009
Completion Date
February 1, 2009
Last Updated
December 9, 2013
NCT07233096
NCT06717919
NCT06899867
NCT05237583
NCT06682325
NCT06890234
Lead Sponsor
The University of Texas Health Science Center, Houston
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions